Skip to main content
Veterinary Medicines

CUNIPRAVAC

Authorised
  • Bordetella bronchiseptica, strain 527, Inactivated
  • Pasteurella multocida, serotype A, strain 267, Inactivated

Product identification

Medicine name:
CUNIPRAVAC
Active substance:
  • Bordetella bronchiseptica, strain 527, Inactivated
  • Pasteurella multocida, serotype A, strain 267, Inactivated
Target species:
  • Rabbit
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain 527, Inactivated
    40.00
    Antibody microagglutination-lytic reaction
    /
    0.50
    millilitre(s)
  • Pasteurella multocida, serotype A, strain 267, Inactivated
    4.00
    Antibody microagglutination-lytic reaction
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AB01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • (AEMPS)
Authorisation number:
  • 2964 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."